Continuing Education

Pharmacological and Psychological Interventions for Weight Loss (Archived)

Morgan T. Sammons, PhD, ABPP

The recent introduction of a new class of drug for weight loss, the glucagon-like-peptide 1 receptor agonists (GLP-1, e.g., Rybelsus, Saxenda), has aroused intense public interest. Dr. Sammons discusses the history of drugs used for weight loss with a focus on agents introduced in the recent past. He covers efficacy, mechanisms of action, risks and benefits, and combination with psychological and behavioral weight loss regimens. Dr. Sammons also discusses the ethics of pharmacological interventions for weight loss.

Disclosure: Dr. Sammons is currently a member of the Board of Directors of the Canadian Register of Health Service Psychologists. 

Year 2023
Credit 1
Level Intermediate
Price $35.00
Learning Objectives
  1. Describe past and present pharmacological agents for weight loss.
  2. Discuss the putative mechanisms of action and efficacy of GLP-1 agonists.
  3. Explain the evidence supporting combined psychological/behavioral interventions for weight loss.

Shopping Cart

There are no items in your cart

Video CE Credits in Cart

Your purchase provides you with one year of access for each selected item.

Total: $0.00